✦ LIBER ✦

Cytokines in the pathophysiology and treatment of chronic B-cell malignancies

✍ Scribed by M. Schuler; C. Huber; C. Peschel

Publisher: Springer
Year: 1995
Tongue: English
Weight: 833 KB
Volume: 71
Category: Article
ISSN: 0939-5555
DOI: 10.1007/bf01699247

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modulation of apoptosis by cytokines in

Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia

✍ R. Castejón; J.A. Vargas; Y. Romero; M. Briz; R.M. Muñoz; A. Durántez 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the slow and progressive accumulation of monoclonal apparently mature, CD5 ؉ B lymphocytes. The majority of circulating cells appear to be nondividing, and it has been suggested that a prolonged life span is mainly responsible for the a

The role of chemokines in B cell chronic

The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact

✍ Percy Schröttner; Marion Leick; Meike Burger 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 461 KB

Circulating levels of cytokines and solu

Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies

✍ Syed Raziuddin; Anwar Sheikha; Saeed Abu-Eshy; Mansour Al-Janadi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

Purine degradative enzymes in circulatin

Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia

✍ Anthony D. Ho; Wolfgang Knauf; Kanagabasai Ganeshaguru; Werner Hunstein; A. V. H 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Previous reports have shown that the purine degradative enzymes adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP) and ecto-5'-nucleotidase (S'NT), play an important role in the normal development of lymphocytes and that investigations of these enzymes are of value in defining subsets

Serum beta-2 microglobulin as a marker o

Serum beta-2 microglobulin as a marker of B-cell activation in chronic lymphoid malignancies

✍ Shvidel, Lev; Hofstein, Ronny; Berrebi, Alain 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Treatment of B cell malignancies with 13

Treatment of B cell malignancies with 131I LYM-1 monoclonal antibodies

✍ S. J. Denardo; G. L. Denardo; L. F. O'Grady; E. Hu; V. M. Sytsma; S. L. Mills; N 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 689 KB

Lym-I is a murine IgG2, monoclonal antibody (MAb) that is B-cell specific but has greater avidity for malignant B cells when compared with normal B lymphocytes. It was originally produced by immunizing mice with nuclei of cultured cells from a patient with Burkitt's lymphoma. Ten patients with progr